| Medical Director Europe | |
| Ocera Warsaw, Poland Ref: EP040-01 |
|
The RoleThe Roleprovide medical support to all clinical investigations taking place in Europe ensuring safety issues are addressed on a timely manner participate in all key-GE congresses taking place in Europe participate in weekly conference calls with ocera San Diego CA and CROs reports to Chief Medical Officer position can be based wherever in central Europe (PL,H,CZ) |
RequirementsRequirementsexcellent english communication skills; knowledge of central european languages and german woud be a plus experience of clinical trials management, in particular in Gastro-Enterology would be a plus professional individual who is self-motivated as well as a team player ability to inteact positively with clinical operations, CROs, investigators in multiple geopgraphies |
About the CompanyAbout the CompanyOcera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases. Our initial product candidate, AST-120, is currently in pivotal Phase III clinical testing in North America and Europe for the treatment of fistulizing Crohn’s disease, a form of inflammatory bowel disease that afflicts more than 500,000 in the U.S.. In-licensed from Kureha Corporation of Tokyo, AST-120 is an oral drug marketed in Japan to delay the time to dialysis and reduce uremic symptoms in patients with chronic kidney disease. A well-established safety profile for AST-120 has been demonstrated, based on its administration to more than 200,000 Japanese patients to date. Promising efficacy and safety data from Japanese clinical trials have also shown the potential of AST-120 to treat mild to moderate fistulizing Crohn’s disease. Ocera’s goal is to develop safe and novel therapies that address large unmet medical needs in the treatment of major gastrointestinal and liver diseases. Ocera has assembled an executive management team with broad experience in developing and launching pharmaceutical products at both large and emerging growth companies. The company is organized to provide high efficiency in clinical development, regulatory affairs and licensing, with the goal of building a strong product pipeline, and developing compounds for accelerated commercialization of much-needed products for debilitating diseases. |
....